Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;15(Suppl 2):249S–254S. doi: 10.1111/j.1365-2125.1983.tb05872.x

Mianserin, maprotiline and intracardiac conduction

J Guy Edwards, Ann Goldie
PMCID: PMC1427885  PMID: 6824556

Abstract

1 High speed surface electrocardiograms were recorded in 35 patients during the baseline and after four weeks' treatment in a placebo-controlled trial of mianserin and maprotiline in primary depressive illness.

2 Measurements of the RR, PR and QT intervals, QRS width and T wave height were made blind to patient, drug and treatment interval and compared with plasma drug concentrations. The presence or absence of cardiac arrhythmias was recorded.

3 The only significant findings were an increased heart rate and PR interval and decreased QTc interval in the maprotiline group. Only one patient receiving maprotiline had a cardiac arrhythmia. There was no significant correlation between measurements of ECG parameters and plasma drug levels.

4 The results confirm the lack of cardiac effects of mianserin and show both anticholinergic activity and effects of an intracardiac conduction in the case of maprotiline. The mechanisms of these effects are discussed.

Full text

PDF
249S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnve S., Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation. 1982 Mar;65(3):435–439. doi: 10.1161/01.cir.65.3.435. [DOI] [PubMed] [Google Scholar]
  2. Bethge K. P., Godt U., Blanco-Cruz E., Lichtlen P. R. Incidence of cardiac arrhythmias during antidepressant therapy with maprotiline or nomifensine. J Cardiovasc Pharmacol. 1982 Jan-Feb;4(1):142–148. doi: 10.1097/00005344-198201000-00023. [DOI] [PubMed] [Google Scholar]
  3. Burckhardt D., Raeder E., Müller V., Imhof P., Neubauer H. Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA. 1978 Jan 16;239(3):213–216. [PubMed] [Google Scholar]
  4. Burgess C. D., Montgomery S. A., Montgomery D. B., Wadsworth J. Cardiovascular effects of amitriptyline, mianserin and zimelidine in depressed patients. Prog Neuropsychopharmacol. 1980;4(4-5):523–526. doi: 10.1016/0364-7722(80)90024-7. [DOI] [PubMed] [Google Scholar]
  5. Burgess C. D., Montgomery S., Wadsworth J., Turner P. Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J. 1979 Oct;55(648):704–708. doi: 10.1136/pgmj.55.648.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burrows G. D., Davies B., Hamer A., Vohra J. Effect of mianserin on cardiac conduction. Med J Aust. 1979 Jul 28;2(2):97–98. doi: 10.5694/j.1326-5377.1979.tb112744.x. [DOI] [PubMed] [Google Scholar]
  7. Edwards J. G., Goldie A. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report. Br J Clin Pharmacol. 1983;15 (Suppl 2):239S–248S. doi: 10.1111/j.1365-2125.1983.tb05871.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ghose K., Coppen A., Turner P. Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology (Berl) 1976 Sep 17;49(2):201–204. doi: 10.1007/BF00427291. [DOI] [PubMed] [Google Scholar]
  9. Giardina E. G., Bigger J. T., Jr, Glassman A. H., Perel J. M., Kantor S. J. The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation. 1979 Nov;60(5):1045–1052. doi: 10.1161/01.cir.60.5.1045. [DOI] [PubMed] [Google Scholar]
  10. Han J., Goel B. G. Electrophysiologic precursors of ventricular tachyarrhythmias. Arch Intern Med. 1972 May;129(5):749–755. [PubMed] [Google Scholar]
  11. Milne J. R., Camm A. J., Ward D. E., Spurrell R. A. Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J. 1980 Jan;43(1):1–6. doi: 10.1136/hrt.43.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peet M., Tienari P., Jaskari M. O. A comparison of the cardiac effects of mianserin and amitriptyline in man. Pharmakopsychiatr Neuropsychopharmakol. 1977 Dec;10(6):309–312. doi: 10.1055/s-0028-1094554. [DOI] [PubMed] [Google Scholar]
  13. Raeder E. A., Zinsli M., Burckhardt D. Effect of maprotiline on cardiac arrhythmias. Br Med J. 1979 Jul 14;2(6182):102–102. doi: 10.1136/bmj.2.6182.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Riess W. The double radio-isotope derivative technique for the assay of drugs in biological material. I. The determination of maprotiline. Anal Chim Acta. 1974 Feb;68(2):363–376. doi: 10.1016/s0003-2670(01)82591-5. [DOI] [PubMed] [Google Scholar]
  15. Seides S. F., Josephson M. E., Batsford W. P., Weisfogel G. M., Lau S. H., Damato A. N. The electrophysiology of propranolol in man. Am Heart J. 1974 Dec;88(6):733–741. doi: 10.1016/0002-8703(74)90283-x. [DOI] [PubMed] [Google Scholar]
  16. Singh B. N., Hauswirth O. Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J. 1974 Mar;87(3):367–382. doi: 10.1016/0002-8703(74)90080-5. [DOI] [PubMed] [Google Scholar]
  17. Stern S., Eisenberg S. The effect of propranolol (Inderal) on the electrocardiogram of normal subjects. Am Heart J. 1969 Feb;77(2):192–195. doi: 10.1016/0002-8703(69)90350-0. [DOI] [PubMed] [Google Scholar]
  18. Veith R. C., Friedel R. O., Bloom V., Bielski R. Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmacol Ther. 1980 Jun;27(6):796–802. doi: 10.1038/clpt.1980.113. [DOI] [PubMed] [Google Scholar]
  19. Wester H. A., Siegers C. P. Cardiovascular effects of mianserin and amitriptyline in healthy volunteers. Int J Clin Pharmacol Ther Toxicol. 1980 Dec;18(12):513–517. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES